Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TIGLUTIK® safely and effectively. See full prescribing information for TIGLUTIK. TIGLUTIK (riluzole) oral suspension Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
- generic_name
- riluzole
- product_names
- Riluzole
- ndc
- 70726-0303, 70726-0303-2, 70726-0303-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en